期刊文献+

肿瘤抗原负载的DC-CIK细胞增殖能力及对肝癌细胞HepG2的杀伤活性研究 被引量:1

Study of proliferation ability of tumor antigen-loaded DC-CIK cells and its killing effect on hepatocarcinoma cells HepG2
原文传递
导出
摘要 目的观察肿瘤抗原负载的树突状细胞(DC)与细胞因子诱导的杀伤细胞(CIK)共培养后的增殖能力及对肝癌细胞HepG2的杀伤活性。方法采用液氮反复冻融法制备肝癌细胞HepG2抗原。应用血细胞分离机采集健康供血者单个核细胞,诱导并分离出DC、CIK,用肿瘤抗原冲击DC获得Ag-DC,将CIK分为3组,一组为单纯CIK,二组以DC∶CIK=1∶5比例混合,三组以Ag-DC∶CIK=1∶5比例混合。3组细胞分别记作:CIK组、DC-CIK组和Ag-DC-CIK组。观察3组细胞的增殖能力和细胞表型,并用四甲基偶氮唑蓝(MTT)法测定3组细胞对肝癌细胞HepG2的杀伤活性。结果3组细胞随着培养时间的延长增殖速度逐渐增快,在共同培养的第9天、第12天和第15天时Ag-DC-CIK的增殖倍数(61.32±1.72、190.83±3.53、399.09±5.60)均明显高于同时间CIK的增殖倍数(22.47±2.07、55.91±1.81、83.20±2.34)和DC-CIK的增殖倍数(40.26±2.49、125.03±4.16、251.55±3.25),3组间差异有统计学意义(F=185.78,P=0.033;F=297.35,P=0.018;F=455.37,P<0.001),进一步两两比较发现,差异均具有统计学意义(均P<0.05)。Ag-DC-CIK对HepG2细胞的杀伤活性在效靶比为5∶1、10∶1和20∶1时分别为31.71%±0.29%、42.43%±1.86%和57.69%±1.11%,均显著高于CIK组(12.11%±1.14%、21.30%±0.52%和30.71%±1.26%)和DC-CIK组(20.06%±0.67%、29.89%±1.37%和39.11%±0.92%),3组间差异有统计学意义(F=159.64,P=0.037;F=199.36,P=0.025;F=302.08,P<0.001),进一步两两比较发现,差异均具有统计学意义(均P<0.05)。CIK、DC-CIK和Ag-DC-CIK 3组细胞培养至第15天,流式细胞仪分析表明3组细胞均表达CD3^+CD8^+、CD3^+CD56^+双阳性细胞,且Ag-DC-CIK组CD3^+CD8^+、CD3^+CD56^+双阳性细胞的含量(88.12%±1.24%、61.35%±2.63%)明显高于CIK组(54.37%±3.08%、18.22%±1.83%)和DC-CIK组(69.80%±1.46%、39.51%±2.17%),3组间差异有统计学意义(F=414.32,P<0.001;F=378.60,P<0.001),进一步两两比较发现,差异均具有统计学意义(均P<0.001)。结论肿瘤抗原负载DC后与CIK共培养获得的Ag-DC-CIK细胞的增殖能力和对肝癌细胞HepG2的杀伤活性显著高于CIK细胞和DC-CIK细胞。 ObjectiveTo observe the proliferation ability of cocultured dendritic cells(DCs)loaded with tumor antigen and cytokine-induced killer cells(CIKs)and its killing effect on hepatocarcinoma cells HepG2.MethodsThe antigen of hepatocarcinoma cells HepG2 was prepared by repeated freezing and thawing of liquid nitrogen.Peripheral blood mononuclear cells(PBMNCs)were isolated from healthy donors by blood cell separator,then DCs and CIKs were induced.Ag-DCs were obtained by impinging DCs with tumor antigens.CIKs were divided into three groups:the first group was CIKs alone,the second group was mixed in the proportion of DCs∶CIKs=1∶5,and the third group was mixed in the proportion of Ag-DCs∶CIKs=1∶5.The three groups of cells were recorded as CIK group,DC-CIK group and Ag-DC-CIK group.The proliferation and cell phenotype of the three groups of cells were observed and the killing effects on hepatocarcinoma cells HepG2 were detected by methyl thiazolyl tetrazolium(MTT)assay.ResultsThe proliferation multiples of the three groups of cells were gradually increased with the prolongation of culture time,and the proliferation rates of Ag-DC-CIK on the 9th day(61.32±1.72),the 12th day(190.83±3.53)and the 15th day(399.09±5.60)were significantly higher than those of CIK group(22.47±2.07,55.91±1.81,83.20±2.34)and DC-CIK group(40.26±2.49,125.03±4.16,251.55±3.25),and the difference between the three group was statistically significant(F=185.78,P=0.033;F=297.35,P=0.018;F=455.37,P<0.001),in addition,the differences between each two groups were statistically significant(all P<0.05).The cytotoxicity of Ag-DC-CIK to HepG2 cells at the effective target ratios of 5∶1(31.71%±0.29%),10∶1(42.43%±1.86%)and 20∶1(57.69%±1.11%)were significantly higher than those of CIK group(12.11%±1.14%,21.30%±0.52%,30.71%±1.26%)and DC-CIK group(20.06%±0.67%,29.89%±1.37%,39.11%±0.92%),and the difference between the three group was statistically significant(F=159.64,P=0.037;F=199.36,P=0.025;F=302.08,P<0.001),in addition,the differences between each two groups were statistically significant(all P<0.05).On the 15th day of cell culture,the flow cytometry analysis showed that all the three groups were expressed CD3^+CD8^+,CD3^+CD56^+double positive cells,the contents of CD3^+CD8^+、CD3^+CD56^+double positive cells in the Ag-DC-CIK group(88.12%±1.24%,61.35%±2.63%)were significantly higher than those in the CIK group(54.37%±3.08%,18.22%±1.83%)and DC-CIK group(69.80%±1.46%,39.51%±2.17%),and the difference between the three group was statistically significant(F=414.32,P<0.001;F=378.60,P<0.001),in addition,the differences between each two groups were statistically significant(all P<0.001).ConclusionThe proliferation ability and killing effect of Ag-DC-CIK that obtained from antigen-pulsed DCs co-cultured with CIKs are significantly higher than those of CIKs and DC-CIKs.
作者 王福立 孙银萍 魏本尊 秦杰 刘振国 李岩 邱菊 Wang Fuli;Sun Yinping;Wei Benzun;Qin Jie;Liu Zhenguo;Li Yan;Qiu Ju(Department of Oncology,Zibo Central Hospital,Shandong Province,Zibo 255000,China;Department of Hepatobiliary Surgery,Zibo Central Hospital,Shandong Province,Zibo 255000,China;Department of Oncology,Gaoqing People's Hospital,Shandong Province,Gaoqing 256300,China;Department of Oncology,Qianfoshan Hospital of Shandong University,Shandong Province,Jinan 250014,China;Department of Ultrasound,Zibo Central Hospital,Shandong Province,Zibo 255000,China)
出处 《国际肿瘤学杂志》 CAS 2019年第1期1-5,共5页 Journal of International Oncology
关键词 树突细胞 杀伤细胞 细胞系 肿瘤 Dendritic cells Killer cells Cell line,tumor
  • 相关文献

参考文献2

二级参考文献24

  • 1Mehta, B.A., I.G. Schmidt-Wolf, I.L. Weissman and R. S. Negrin, 1995, Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3 + CD56 + killer cells. Blood, 86 :3493 - 3499.
  • 2Girolomoni, G. and P. Ricciandi-Lastagnoli, 1997, Dendritic cells hold promise for immumunotherapy. Immunol. Today. ,18:102- 104.
  • 3Shimizu, K. , R.C. Fields., M. Giedlin and J. J. Mule,1999, Systemic administration of interleukin 2 enhances therapeuticefficacy of dendritic cell-based tumor vaccines.Proc. Natl. Acad. Sci. USA., 96:2268 - 2273.
  • 4Schmidt, R.E., C. Murray, J. F. Daley, S.F. Schlossman and J. Ritz, 1986, A subset of natural killer cells inperipheral blood displays a mature T cell phenotype. J.Exp. Med. , 164:351-356.
  • 5Lanier, L.L., A.M. Le, C.I. Civin, M.R. Loken andJ.H. Phillips, 1986,The relationship of CD16(Leu-11)and Leul9(NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J. Immunol., 136: 4480 - 4486.
  • 6Ortaldo, J.R., R.T. Winkler-Pickett, H. Yagita andH.A. Young , 1991, Comparative studies of CD3- and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement and pore-forming protein expression. Cell Immunol., 136: 486 - 495.
  • 7Lu, P. and R.S. Negrin, 1994, A novel population of expanded human CD3 + CD56 + cell derived from T ceilswith potent in vivo antitumor activity in mice with severe combined immunodeficiency. J. Immunol., 153:1687- 1696.
  • 8Schmidt-Wolf, I.G., R.S. Negrin, H.P. Kiem, K.G.Blume and I.L. Weissman, 1991, Use of a SCID mouse/human lymphorna modle to evaluate cytokine-induced killer cells with potent antitumor cell activity. J. Exp.Med. 174:139 - 149.
  • 9Banchereau, J. and R. Steinman, 1998, Dendritic cells and the control of immunity. Nature, 392.245 - 252.
  • 10Hsu, F. J.G. and F. Benike, . 1996,Vaccination of patients with B-cell lymphoma using antologous antigenpulsed antigen-pulsed dendritic cells. Nature. Med. , 2.52 - 58.

共引文献16

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部